| COOPERATION |
Aventis SA (France) has agreed to SELL to German biotech nology Co. Girindus its Cincinnati facilities for development of pharma. active ingredients, radiochemistry, & current Good Mfg Practices pilot mfg. Under the agreement - Girindus will produce pharma. actives at the plant for 3 years for Aventis - Thereafter, Aventis will consider developing a long-term outsourcing partnership with Girindus |
| OBSERVATION'S |
Girindus, sees the acquisition as a way to expand its market presence in the U.S. The proposed acquisition of the Cincinnati facilities will strengthen Girindus' position as a one-stop shop for process development, radiolabeling, scale-up, & production" of pharma active ingredients for preclinical & clinical studies as well as commercialization |
| STATUS | Deal expected to be wrapped up by end of year |
| UPDATE | 09.00 |
| CONTACT | Link Frits; Girindus's CEO |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |